Navigation Links
Marrone Bio Innovations Submits New Bioherbicide for EPA Registration
Date:2/25/2013

Davis, CA (PRWEB) February 25, 2013

Marrone Bio Innovations, Inc. (MBI), a leading global provider of natural pest management products for the agricultural and water treatment markets, announces the submission of a new bioherbicide, MBI-011 EP, to the U. S. Environmental Protection Agency (EPA). This is the second bioherbicide MBI has submitted for approval to the EPA (MBI-005 bioherbicide was EPA-approved in 2012). MBI-011 EP is a post-emergent burndown herbicide that can also be used as a crop desiccant. It has contact activity and no post-application planting restrictions are expected. MBI-011 EP is being submitted for control of annual and perennial grass and broadleaf weeds in the agricultural, non-crop and consumer home and garden markets.

Dr. Phyllis Himmel, MBI vice president of research and development, noted how the product got its start when one of MBI’s chemists screened for herbicidal activity of medicinal herbs. During the testing of 350 different herbs, an extract of dry long pepper (Piper longum L.) fruits showed activity against lettuce seedlings. This active ingredient was identified as sarmentine, a naturally occurring compound that gives black pepper its pungent aroma.

The new bioherbicide offers broad-spectrum control and will provide an alternative to herbicides that are highly prone to resistance. According to the International Survey of Herbicide Resistant Weeds, weeds have developed resistance to 148 different herbicides in 63 crops in 61 countries. “With the continuing and widespread identification of herbicide resistant weeds, we are very excited about submitting this product for registration,” remarks Dr. Pam Marrone, CEO. “It has become increasingly clear that no one product can be the ultimate solution to a weed problem and herbicide users need an array of tools to combat weeds. One of the most important benefits we provide users of all our biopesticide products is helping them strengthen their Integrated Resistance Management (IRM) programs. With our new herbicide, we believe we are making a positive contribution in this area.”

About Marrone Bio Innovations
Marrone Bio Innovations, Inc. is a leading global provider of biopesticides for the agricultural market. Its effective, natural products provide higher crop yields and quality while managing pest resistance and residues. MBI has developed a pipeline of products including several nematicide, fungicide, algaecide and plant health product candidates. The award-winning MBI products for the ag market include Regalia® biofungicide and Grandevo®, a broad-spectrum bioinsecticide. The company recently received EPA approval for Opportune™, a novel bioherbicide and submitted Venerate™, a broad-spectrum contact insecticide discovered through the MBI screening process. MBI currently has more than three dozen patents pending in the U.S. and globally.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10461667.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Marrone Bio Innovations’ Zequanox® Demonstrates Control of Zebra Mussels in Illinois Lake
2. Marrone Bio Innovations’ CEO to Address European Biopesticide Industry at Informa Life Sciences Biopesticides Conference
3. Marrone Bio Innovations Breaks Ground on Michigan Manufacturing Facility
4. Genomic Health Announces Results from Two Studies Demonstrating Innovations in Next Generation Sequencing From Paraffin Tissue, Enhancing Understanding of Tumor Biology
5. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
6. Prism Awards Honor Innovations in ‘Ubiquitous’ Photonics Technology
7. LATISTA Announces Next-Generation iPad App 2.0 for Construction with Industry Leading Innovations
8. Wake Forest Innovations Partners with Veterinary Bioscience Institute to Develop Educational Programs for Life Science Professionals
9. The Scientist Proudly Announces the Top 10 Innovations of 2012
10. New Report: "Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance" Now Available at Twease.org
11. Heartland Plant Innovations Wins Kansas Bioscience Authority Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... line of intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining ... Chicago. The result of a collaboration among several companies with expertise in toolholding, ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
Breaking Biology News(10 mins):